Mestastop Solutions
Mestastop Solutions is a specialized biotechnology company focused on combating cancer metastasis, the leading cause of cancer mortality. The company leverages proprietary platform technologies including METAssayTM and ReSULT, which integrate in vitro, in vivo, ex vivo assays, genetic engineering, machine learning, and clinical sampling to identify novel drug targets, repurpose existing drugs, and develop companion diagnostics for early metastasis detection and treatment. Their business model includes research oncology solutions for drug discovery, drug repurposing, and clinical translation, aiming to improve clinical trial success and patient outcomes. Supported by venture capital and government grants, Mestastop is positioned as a leader in metastasis research with a strong team of industry veterans and academic experts, targeting a global oncology market with unmet needs in metastasis prevention and treatment.
Mestastop Solutions
Mestastop Solutions is a specialized biotechnology company focused on combating cancer metastasis, the leading cause of cancer mortality. The company leverages proprietary platform technologies including METAssayTM and ReSULT, which integrate in vitro, in vivo, ex vivo assays, genetic engineering, machine learning, and clinical sampling to identify novel drug targets, repurpose existing drugs, and develop companion diagnostics for early metastasis detection and treatment. Their business model includes research oncology solutions for drug discovery, drug repurposing, and clinical translation, aiming to improve clinical trial success and patient outcomes. Supported by venture capital and government grants, Mestastop is positioned as a leader in metastasis research with a strong team of industry veterans and academic experts, targeting a global oncology market with unmet needs in metastasis prevention and treatment.